Doctors and aid workers warn that the freeze to USAID-funded TB programs is likely to cause thousands of unnecessary deaths ...
Bedaquiline, the first new TB drug approved in 40 years by the USFDA, faced several challenges, including initial trial ...
TB can be found in every major city, in every country. Failing to control it threatens global health security. Now is not the ...
"At the time, I knew almost nothing about TB. To me, it was a disease of history — something that killed depressive ...
Clinical Trials Arena on MSN7d
Rising Sirturo resistance highlights urgent need for new TB therapiesToday marks World TB Day 2025 with the WHO calling for more investment into TB treatment and research globally.
The Conversation on MSN8d
Tuberculosis was once a disease in decline, but a resurgence in cases has health officials puzzledTuberculosis is the leading infectious cause of death around the world, outpaced only by COVID-19 during the first three ...
Tuberculosis (TB) remains a global health challenge, affecting millions each year. Globally, an estimated 10.8 million people ...
Under the BioVersys and GSK collaboration agreement, GSK is evaluating the early bactericidal activity (EBA) of alpibectir-ethionamide (AlpE) in a pulmonary tuberculosis (TB) trial, in combination ...
Pediatric TB cases are rising across Europe and Central Asia, indicating ongoing transmission and raising concern around ...
India: A recent study conducted in a high-endemic region highlights the role of chest X-rays (CXR) in identifying ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback